ANDA 75976, held by Pharmobedient. Metformin Hydrochloride.
As of Nov 16, 2026, ANDA 75976 (Metformin Hydrochloride), held by Pharmobedient, was first approved by FDA on Jan 24, 2002, with 10 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 24, 2002 | Original application | Approved | None posted |
| Metformin Hydrochloride500MG · tablet;oral | Metformin Hydrochloride | Discontinued |
| Metformin Hydrochloride850MG · tablet;oral | Metformin Hydrochloride | Discontinued |
| Metformin Hydrochloride1GM · tablet;oral | Metformin Hydrochloride | Discontinued |
| Aug 11, 2026 | Supplement 24Labeling · Standard review | Approved | None posted |
| Nov 14, 2019 | Supplement 21Labeling · Standard review | Approved | None posted |
| Nov 14, 2019 | Supplement 20Labeling · Standard review | Approved | None posted |
| Sep 29, 2010 | Supplement 17Labeling | Approved | None posted |
| Mar 8, 2007 | Supplement 14Labeling | Approved | None posted |
| Sep 21, 2004 | Supplement 8Labeling | Approved | None posted |
| May 14, 2004 | Supplement 7Labeling | Approved | None posted |
| Aug 14, 2003 | Supplement 4Labeling | Approved | None posted |
| Oct 3, 2002 | Supplement 2Manufacturing | Approved | None posted |
| Apr 11, 2002 | Supplement 1Labeling | Approved | None posted |
| Jan 24, 2002 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters